Showing results (521-530 of 691) with videos related to

Sort By:
Pageof 70
Clinical Science (London, England : 1979)|July 1, 1987
Free D-amino acids in human plasma in relation to senescence and renal diseasesY Nagata, T Akino, K Ohno, et al.
Acta Oncologica (Stockholm, Sweden)|July 11, 1998
Radiotherapy combined with transcatheter arterial infusion chemotherapy for locally advanced cervical cancerM Kokubo, K Tsutsui, Y Nagata, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|August 11, 2011
Orbital magnetic moment in Ir doped CaMnO(3)S Mizusaki, Y Toyoda, T Ohnishi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1993
GD2 ganglioside on human T-lymphotropic virus type I-infected T cells: possible activation of beta-1,4-N-acetylgalactosaminyltransferase gene by p40taxK Furukawa, T Akagi, Y Nagata, et al.
No Shinkei Geka. Neurological Surgery|June 1, 1992
[Management of elderly patients with aneurysmal subarachnoid hemorrhage]T Yasui, H Yagura, M Komiyama, et al.
Prostate Cancer and Prostatic Diseases|January 9, 2008
Age-stratified serum levels of isoflavones and proportion of equol producers in Japanese and Korean healthy menK Fujimoto, M Tanaka, Y Hirao, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 1993
Induction of erythroid-specific gene expression in lymphoid cellsT Chiba, Y Nagata, A Kishi, et al.
Journal of Neurosurgery|October 1, 1992
Significance of gadolinium-enhanced magnetic resonance imaging in differentiating spinal cord radiation myelopathy from tumor. Case reportT Yasui, H Yagura, M Komiyama, et al.
Brain Research|June 6, 1998
Increase of glial fibrillary acidic protein fragments in the spinal cord of motor neuron degeneration mutant mouseK Fujita, M Yamauchi, T Matsui, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 7, 2018
Impaired residual renal function predicts denosumab-induced serum calcium decrement as well as increment of bone mineral density in non-severe renal insufficiencyD Miyaoka, Y Imanishi, M Ohara, et al.
Pageof 70